N-Methyl 2-bromo-4-fluoroaniline, HCl, 97%, 250mg

3-((Bis(diisopropylamino)phosphino)oxy)-propanenitrile, 90.0%, 10g

4,4'-(Cyclopent-1-ene-1,2-diyl)bis(5-methylthiophene-2-carbaldehydE), 97%, 250mg

(1S,2S,5S)-(-)-2-Hydroxy-3-pinanone>98.0%(GC)1g

3-Phenyl-3-(trifluoromethyl)-3H-diazirine, 98%, 5g

(3-Phenoxyphenyl)methanamine, 95.0%, 10g

tert-butyl 5-oxo-1H,2H,4H,5H,6H,6aH-cyclopenta[c]pyrrole-2-carboxylate, 95%, 100mg

N-Benzyl-N,N'-dimethylethylenediamine>98.0%(GC)(T)5g

3-Methyl-3-phenylcyclobutan-1-one, 98%, 100mg

4-(4-Bromophenyl)-2,6-diphenylpyridine, 95+%, 1g

4-n-Propylbenzoylacetonitrile, 96.0%, 1g

Colonna capillare per GC ROTI®Cap-5 MS Ultra, 60 m, 0.32 mm, 1.00 µm, 1 Pezzo(i)

1-(Propane-1-sulfonyl)piperazine hydrochloride, 95%, 5g